Bringing the fundamentals into focus…
Back to Omnicell, Inc.
How Omnicell, Inc. stacks up
OMCL · against 447 other Healthcare companies of similar size
Valuation
55/ 100
Above the middle of the pack.
Ranked #214 of 448 · scores higher than 52% of peers
Bars: peers in each 10-point band of the valuation score37 peers with a valuation score of 50–59, including OMCL · Click a bar to see the companies
Why valuation scores 55?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings yield is close to the peer norm. Earnings yield: 2.4% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 5.4% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 90% of peers. Free cash flow yield: 8.8% vs peer median 0.0%
Metric by metric
Position: dot = OMCL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | OMCL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 436 reported | 2.4% | 1.5% | 56% | 30% | |
| EBITDA yieldHigher is better · 449 reported | 5.4% | 4.3% | 57% | 50% | |
| Free cash flow yieldHigher is better · 203 reported | 7.9% | -0.5% | 87% | 20% | |
| Book yieldHigher is better · 438 reported | 79.9% | 37.9% | 85% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around OMCLScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score